GlaxoSmithKline PLC (GSK.L)
18 Dec 2017
Latest Key Developments (Source: Significant Developments)
Dec 18 (Reuters) - GLAXOSMITHKLINE
Glaxosmithkline Submits Regulatory Application For Single-Dose Tafenoquine For Treatment Of Plasmodium Vivax Malaria
Dec 14 (Reuters) - Glaxosmithkline Plc
Dec 12 (Reuters) - U.S. Food and Drug Administration::SAYS EXPANDED APPROVED USE OF NUCALA (MEPOLIZUMAB) TO TREAT ADULT PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS.SAYS GRANTED APPROVAL OF NUCALA TO GLAXOSMITHKLINE. Full Article
Dec 6 (Reuters) - Glaxosmithkline Plc
Dec 6 (Reuters) - Australian Competition and Consumer Commission:INSTITUTED PROCEEDINGS AGAINST GLAXOSMITHKLINE HEALTHCARE AUSTRALIA PTY LTD (GSK) AND NOVARTIS CONSUMER HEALTH AUSTRALASIA.PROCEEDINGS ALLEGING THEY MADE FALSE OR MISLEADING REPRESENTATIONS IN MARKETING OF VOLTAREN OSTEO GEL AND VOLTAREN EMULGEL PAIN RELIEF PRODUCTS.SEEKING DECLARATIONS, INJUNCTIONS, PECUNIARY PENALTIES, A PUBLICATION ORDER, THE IMPOSITION OF A COMPLIANCE PROGRAM AND COSTS. Full Article
Dec 5 (Reuters) - John Wood Group Plc
Nov 30 (Reuters) - GLAXOSMITHKLINE PLC
Nov 28 (Reuters) - GLAXOSMITHKLINE PLC
Nov 21 (Reuters) - U.S. Food and Drug Administration::Approved Juluca, a fixed-dose tablet containing dolutegravir and rilpivirine, to treat adults with HIV-1 infections .Granted approval of Juluca to ViiV Healthcare. Full Article
Nov 16 (Reuters) - Glaxosmithkline Plc
- How safe is GlaxoSmithKline plc’s dividend?
- Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?
- Which of these Neil Woodford dividend stocks should you buy today?
- 3 blue chip bargains you can't afford to miss!
- Are these 3 top stocks still mighty income machines?
- Now is the perfect time to buy these 3 healthcare stocks!